维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="DAVER A"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Influence of Scanning Doses of Iodine-131 on Subsequent First Ablative Treatment Outcome in Patients Op- erated on for Differentiated Thyroid Carcinoma 显示文摘	Muratet JP Daver A Minier JF	1998	J NucI Med1998，39，9：	1
2	Study of serum homocysteine, folic acid and vitamin B (12) in patients with preeclampsia显示文摘	Shahid A Mujawar Vinayak W Patil Rekha G Daver	2011	Indian journal of clin- ical biochemistry : IJC B2011，26，3：	1
3	Thymidine kinase as a proliferative marker: clinical relevance in 1692 primary breast cancer patients 显示文摘	Brot P Romain S Daver A	2001	J Clin Oncol2001，19，：	1
4	Thymidine kinase as a prolifer- ative marker: clinical relevance in 1692 primary breast cancer patients显示文摘	Brot P Romain S Daver A	2001	J Clin Oneol2001，19，11：	1
5	Thymidine Kinase as a proliferative marker:clinical relevance in 1,692 primary bresast cancer patients显示文摘	Broet P Romain S Daver A		0，，11：	1
6	Influence of Scanning Doses of Iodine-131 on Subsequent First Ablative Treatment Outcome in Patients Operated on fo r D ifferent iated Thyroid Carcinoma显示文摘	M uratet J P Daver A M inier J F	1998	J Nucl Med1998，39，9：	1
7	Thymidine kinase as a proliferative marder:clinical relevance in 1 692 primary breast caner patients显示文摘	Bro(e)t P Romain S Daver A	2001	J Clin Oncol2001，19，11：	1
8	Thymidine kinase as a proliferative marker: clinical relevance in 1,692 primary breast cancer patients 显示文摘	Broet P Romain S Daver A	2001	J Clin Oncol2001，19，11：	1
9	Thymidine kinase as a proliferative marker: clinical relevance in 1,692 primary breast cancer patients 显示文摘	BROET P ROMAIN S DAVER A	2001	J Clin Oncol2001，19，11：	1
10	A phase II open-label study of the intravenous ad- ministration of homoharringtoninein the treatment of myelodysplastic syndrome 显示文摘	DAVER N VEGA-RUIZ A KANTARJIAN H M	2013	Eur J Cancer Care (Engl)2013，22，：	1
11	Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma显示文摘	Muratet JP Giraud P Daver A	1997	J Nucl Med1997，38，：	1
12	Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentia differentiated thyroid carcinoma显示文摘	Muratet JP Daver A Minier JF		0，，09：	1
13	Influence of scanning dose of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma显示文摘	Muratet JP Daver A Minier JF	1998	J Nucl Med1998，39，：	1
14	Predicting the efficacy of first iodine- 131 treatment in differentiated thyroid carcinoma显示文摘	Muratet JP Giraud P Daver A	1997	J Nucl Med1997，38，9：	1
15	A Prognostic Model of Therapy-Related Myelodysplastic Syndrome for Predicthag Sur- vival and Transformation to Acute Myeloid Leukemia显示文摘	Ouintas-Cardama A Daver N Kim H	2014	Clin Lymphoma Myeloma Leuk2014，14，5：	1
16	A phase II open - la- bel study of the intravenous administration of homoharringtonine in the treatment of myelodysplastic syndrome 显示文摘	Daver N Vega Ruiz A Kantarjian HM	2013	Eur J Cancer Care2013，22，5：	1
17	Thymidine kinase as a proliferative marker:clinical relevance in 1,692 primary breast cancer patients显示文摘	Bro?t P Romain S Daver A	2001	J Clin Oncol2001，19，11：	1
18	Thymidine kinase as a pro-liferative marker:clinical relevance in 1692 primary breastcancer patients显示文摘	Broet P Romain S Daver A	2001	J Clin Oncol2001，19，11：	1
19	Thymidine kinase as a prolif- erative marker: clinical relevance in 1 692 primary breast cancer patients 显示文摘	Broet P Romain S Daver A	2001	J Clin Oncol2001，19，11：	1
20	Influence of Scanning Doses of Iodine-131 on Subsequent First Ablative Treatment Outcome in Patients Operated on for Differentiated Thyroid Carcinoma显示文摘	Daver A Minier JF	1998	J Nucl Med1998，39，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示